TickerFactsScreenerDevelopers

Emergent BioSolutions Inc. (EBS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $33.29M2010: $22.10M2011: $54.03M2012: $53.84M2013: $42.02M2014: $30.67M2015: $44.81M2016: $76.20M2017: $54.80M2018: $72.10M2019: $86.90M2020: $141.90M2021: $224.10M2022: $115.80M2023: $51.60M2024: $22.90M2025: $13.80M$13.80M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$13.80M-39.7%
2024$22.90M-55.6%
2023$51.60M-55.4%
2022$115.80M-48.3%
2021$224.10M+57.9%
2020$141.90M+63.3%
2019$86.90M+20.5%
2018$72.10M+31.6%
2017$54.80M-28.1%
2016$76.20M+70.0%
2015$44.81M+46.1%
2014$30.67M-27.0%
2013$42.02M-22.0%
2012$53.84M-0.3%
2011$54.03M+144.5%
2010$22.10M-33.6%
2009$33.29M—